story of the week
Transitioning From S1P Receptor Modulators to B Cell–Depleting Therapies in MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Transitioning From S1P Receptor Modulators to B Cell-Depleting Therapies in Multiple Sclerosis: Clinical, Radiographic, and Laboratory Data
Neurol Neuroimmunol Neuroinflamm 2022 Jul 01;[EPub Ahead of Print], WM Rowles, WY Hsu, K McPolin, A Li, S Merrill, CY Guo, AJ Green, JM Gelfand, RM BoveFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.